Head and neck cancer combo study pulled before starting
NCT ID NCT01326468
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 31 times
Summary
This study was designed to find a safe dose of the drug Torisel when added to standard chemotherapy and radiation for people with advanced head and neck cancer. The goal was to see if the combination could be given safely and help prevent the cancer from coming back. However, the study was withdrawn before any participants were enrolled.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.